Family Resource Home Care, Inc. – Trademark Portfolio
Entity Type: 03
Family Resource Home Care, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FAMILY RESOURCE HOME CARE. The owner is based in Seattle, WA.
Suite 215
10700 Meridian Avenue North
Seattle, WA 98133
Showing of trademarks Trademarks
Trademark Classifications
Family Resource Home Care, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Family Resource Home Care, Inc. have?
Family Resource Home Care, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.
What trademark classes does Family Resource Home Care, Inc. file in?
Family Resource Home Care, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Family Resource Home Care, Inc.'s most well-known trademarks?
Family Resource Home Care, Inc.'s registered trademark portfolio includes well-known marks such as FAMILY RESOURCE HOME CARE. These are among 1 currently registered trademark in the portfolio.
What is Family Resource Home Care, Inc.'s trademark registration success rate?
Family Resource Home Care, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.